The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families

Author： Radominska-Pandya Anna   Bratton Stacie M.   Redinbo Matthew R.   Miley Michael J.  

Publisher： Informa Healthcare

ISSN： 0360-2532

Source： Drug Metabolism Reviews, Vol.42, Iss.1, 2010-02, pp. : 133-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human UDP-Glucuronosyltransferase 2B7

By  

Current Drug Metabolism, Vol. 2, Iss. 3, 2001-09 ,pp. : 283-298

Bentham Science Publishers

Access to resources Recommend Favorite

Arbidol exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A9 and 2B7

By Liu Xin   Huang Ting   Chen Jian-Xing   Zeng Jia   Fan Xu-Ran     Yu Zhen-Wen   Sun Xiao-Yu   Hong Mo   Sun Hong-Zhi  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 12, 2013-12 ,pp. : 945-950

Govi-Verlag

Access to resources Recommend Favorite

Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes

By Mano Yuji   Usui Takashi   Kamimura Hidetaka  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 2, 2007-02 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite

UDP-Glucuronosyltransferase 2B7 C802T (His268Tyr) Polymorphism in Bladder Cancer Cases

By Zimmermann Anna   Blaszkewicz Meinolf   Roth Gerhard   Seidel Thilo   Dietrich Holger   Schutschkow Olga   Bolt Hermann   Golka Klaus  

Journal of Toxicology and Environmental Health, Vol. 71, Iss. 13-14, 2008-01 ,pp. : 911-914

Taylor & Francis Ltd

Access to resources Recommend Favorite

Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7

By Tsoutsikos P.   Miners J.O.   Stapleton A.   Thomas A.   Sallustio B.C.   Knights K.M.  

Biochemical Pharmacology, Vol. 67, Iss. 1, 2004-01 ,pp. : 191-199

Elsevier

Access to resources Recommend Favorite